SCHEMBL7970177

SCHEMBL7970177

CSc1ccc(C(=O)NN2CCN(C(C)=O)CC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.50
CYP2D6 P10635 2/20 0.49
ALDH1A1 P00352 6/20 0.44
HPGD P15428 5/20 0.44
HSD17B10 Q99714 3/20 0.44
HTT P42858 1/20 0.43
TNF P01375 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAPT P10636 2/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
GAA P10253 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
USP2 O75604 1/20 0.40
TP53 P04637 1/20 0.40
MAPK1 P28482 1/20 0.40
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7972839 0.83 CYP2D6 (0.53) CYP2D6ALDH1A1HPGDHSD17B10HTT
SCHEMBL8018069 0.83 CYP2D6 (0.53) CYP2D6ALDH1A1HPGDHSD17B10HTT
SCHEMBL194951 0.82 CYP2D6 (0.72) CYP2D6ALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL14590778 0.81 HTT (0.65) CYP2D6HTTSMN1; SMN2MAPTCYP2C9
SCHEMBL7968909 0.81 CYP2D6 (0.50) CYP2D6ALDH1A1HPGDHSD17B10HTT
Water SCHEMBL3089403 0.81 CYP2D6 (0.70) CYP2D6ALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL7975155 0.79 HPGD (0.50) CYP2D6ALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL7972482 0.79 CYP2D6 (0.49) CYP2D6ALDH1A1HPGDHTTMAPT
SCHEMBL7972123 0.79 CYP2D6 (0.52) CYP2D6HPGDHSD17B10HTTSMN1; SMN2
SCHEMBL7972302 0.79 MAPT (0.60) CYP2D6ALDH1A1HPGDHSD17B10HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291464-B1 POTENTIATION OF THE CHOLINERGIC ACTIVITY; THERAPEUTIC TREATMENT OF AMNESIA, DEMENTIA OR SENILE DEMENTIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-09-18 US disclosed
EP-0968201-A2 NEW AMINOPIPERAZINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-01-05 EP disclosed
WO-1998035951-A2 NEW AMINOPIPERAZINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-08-20 WO disclosed